Literature DB >> 33715257

Development of a rat model for type 2 diabetes mellitus peri-implantitis: A preliminary study.

Qingqing He1, Zhixiang Mu1,2, Annie Shrestha3, Chao Wang1, Si Wang1, Han Tang1, Yihan Li1, Jinlin Song1, Ping Ji1, Yuanding Huang1, Tao Chen1.   

Abstract

OBJECTIVE: To develop an in vivo model to simulate the complex internal environment of diabetic peri-implantitis (T2DM-PI) model for a better understanding of peri-implantitis in type 2 diabetic patients.
MATERIALS AND METHODS: Maxillary first molars were extracted in Sprague-Dawley (SD) rats, and customized cone-shaped titanium implants were installed in the extraction sites. Thereafter, implants were uncovered and customized abutments were screwed into implants. A high-fat diet and a low-dose injection of streptozotocin were utilized to induce T2DM. Finally, LPS was locally injected in implant sulcus to induce peri-implantitis.
RESULTS: In the present study, T2DM-PI model has been successfully established. Imaging analysis revealed that abundant inflammatory cells infiltrated in the soft tissue in T2DM-PI group with concomitant excessive secretion of inflammatory cytokines. Moreover, higher expression of MMP and increased number of osteoclasts led to collagen disintegration and bone resorption in T2DM-PI group.
CONCLUSIONS: These results describe a novel rat model which stimulate T2DM-PI in vivo, characterized by overwhelming inflammatory response and bone resorption. This model has a potential to be used for investigation of initiation, progression and interventional therapy of T2DM-PI.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  dental implants; diabetes mellitus; in vivo model; peri-implantitis; rats

Mesh:

Substances:

Year:  2021        PMID: 33715257     DOI: 10.1111/odi.13845

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   4.068


  1 in total

1.  Efficiency of Nanohydroxyapatite on Repairing Type II Diabetes Dental Implant-Bone Defect.

Authors:  Dong Ji; Dapeng Lu
Journal:  Biomed Res Int       Date:  2022-06-28       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.